BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7042842)

  • 1. Detection of a tumor-associated antigen on the surface of human myelogenous leukemia cells.
    Malcolm AJ; Shipman RC; Levy JG
    J Immunol; 1982 Jun; 128(6):2599-603. PubMed ID: 7042842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A monoclonal antibody to myelogenous leukemia: isolation and characterization.
    Malcolm AJ; Shipman RC; Logan PM; Levy JG
    Exp Hematol; 1984 Aug; 12(7):539-47. PubMed ID: 6589167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody against a unique antigen on human acute promyelocytic leukemia cell line (HL-60).
    Aota F; Chang D; Hill NO; Khan A
    Exp Hematol; 1982 Nov; 10(10):835-43. PubMed ID: 6759147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of heteroantisera to human acute leukemia-associated antigens.
    Baker MA; Ramachandar K; Taub RN
    J Clin Invest; 1974 Dec; 54(6):1273-8. PubMed ID: 4140196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human leukemia-associated antigen: relation to a family of surface glycoproteins.
    Pesando JM; Ritz J; Levine H; Terhorst C; Lazarus H; Schlossman SF
    J Immunol; 1980 Jun; 124(6):2794-9. PubMed ID: 6989907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of both T-cell and Ia-like antigens on cells from patients with acute myelomonocytic leukemia and chronic myelogenous leukemia in blast crisis.
    Anderson JK; Moore JO; Metzgar RS
    Cancer Res; 1979 Dec; 39(12):4810-5. PubMed ID: 91428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graft-versus-leukemia target antigens in chronic myelogenous leukemia are expressed on myeloid progenitor cells.
    Wu CJ; Biernacki M; Kutok JL; Rogers S; Chen L; Yang XF; Soiffer RJ; Ritz J
    Clin Cancer Res; 2005 Jun; 11(12):4504-11. PubMed ID: 15958636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of an in vitro inhibitor of normal myelopoiesis using a monoclonal antibody directed to a common antigen of myelogenous leukemia (CAMAL).
    Shellard JE; Leitch HA; Logan PM; McMaster WR; Levy JG
    Exp Hematol; 1991 Feb; 19(2):136-42. PubMed ID: 1991495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated surface membrane antigens on CFUs: characterization using the fluorescent activated cell sorter.
    Hasthorpe S; Rogerson J
    Exp Hematol; 1982 Jan; 10(1):9-19. PubMed ID: 7060662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies reactive with acute myelogenous leukemia cells.
    Linker-Israeli M; Billing RJ; Foon KA; Terasaki PI
    J Immunol; 1981 Dec; 127(6):2473-7. PubMed ID: 7028873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of a common leukemia-associated antigen in human myelogenous leukemia using immunoperoxidase.
    Logan PM; Malcolm AJ; Levy JG
    Diagn Immunol; 1984; 2(2):86-100. PubMed ID: 6238754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a monoclonal antibody (5E9) that defines a human cell surface antigen of cell activation.
    Haynes BF; Hemler M; Cotner T; Mann DL; Eisenbarth GS; Strominger JL; Fauci AS
    J Immunol; 1981 Jul; 127(1):347-51. PubMed ID: 6787129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juvenile chronic myelogenous leukemia: surface antigen phenotyping by monoclonal antibodies and cytogenetic studies.
    Shannon K; Nunez G; Dow LW; Weinberg AG; Sato Y; Stastny P; Buchanan GR
    Pediatrics; 1986 Mar; 77(3):330-5. PubMed ID: 3513115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific xenogenous antiserum to cells of chronic myeloid leukemia (CML) in blastic crisis.
    Baryshnikov AJ; Radzikhovskaya RM; Morozova LF; Belyanchikova NI; Slavina EG; Vinogradova JE; Mkheidze DM; Polotskaya TM; Volkova MA; Svet-Moldavsky GJ; Nikitin VD; Kutimov VA; Trubitsina VI; Goletsky SA; Glazunov A
    Biomedicine; 1976 Dec; 25(9):316-7. PubMed ID: 1069594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human acute myelogenous leukemia antigens defined by simian antisera: evidence for leukemia-associated antigens distinct from immune response-associated alloantigens.
    Mohanakumar T; Russell EC; Metzgar RS; Dunn N; Phibbs M; McWilliams NB; Maurer HM
    J Natl Cancer Inst; 1979 May; 62(5):1163-7. PubMed ID: 86633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivity of monoclonal anti-K 562 antibodies with cells of leukemia- and lymphoma-patients.
    Hering S; Böttger V; Baryschnikow AJ; Micheel B
    Arch Geschwulstforsch; 1985; 55(1):9-16. PubMed ID: 3885896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigens shared by leukemic blast cell and lymphoblastoid cell lines detected by lymphocyte-dependent antibody.
    Durantez A; Zighelboim J; Thieme T; Fahey JL
    Cancer Res; 1975 Oct; 35(10):2693-8. PubMed ID: 1057451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody against a differentiation antigen on human leukemia cells: cross-reactivity with rat leukemia and suppression of rat leukemia in vivo.
    Johnson RJ; Shin HS
    J Immunol; 1983 Jun; 130(6):2930-6. PubMed ID: 6406599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of a breast tissue-associated antigen by antiserum to Raji cell-bound circulating immune complexes of human breast cancer.
    Koestler TP; Papsidero LD; Nemoto T; Chu TM
    Cancer Res; 1981 Jul; 41(7):2900-7. PubMed ID: 7018673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strong, specific anti-human leukemia antisera prepared with the use of purified cell membrane antigen.
    Negoro S; Seon BK
    Cancer Res; 1981 Jul; 41(7):2973-6. PubMed ID: 6972802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.